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ABSTRACT
Background. There is mixed evidence regarding the nature of
cognitive function in patients who have undergone renal trans-
plantation. The aim of this meta-analysis was to examine which
cognitive domains are impacted following kidney transplanta-
tion and how performance compares with non-transplanted
patients or healthy controls/normative data.
Method. A systematic search was conducted using keywords
within three databases (Embase, MEDLINE and PsychINFO),
yielding 458 unique studies, 10 of which met the inclusion criteria.
Neuropsychological tests were grouped into nine cognitive
domains and three separate analyses were undertaken within each
domain: (i) within subjects pre- versus post-transplant, (ii) trans-
planted versus non-transplanted patients and (iii) transplanted
versus healthymatched controls and standardized normative data.
Results. Transplanted patients showed moderate to large
improvements in the domains of general cognitive status
(g¼ 0.526), information and motor speed (g¼ 0.558), spatial
reasoning (g¼ 0.376), verbal memory (g¼ 0.759) and visual
memory (g¼ 0.690) when compared with their pre-operative
scores. Test scores in the same ﬁve domains were signiﬁcantly
better in post-transplanted patients when compared with
dialysis-dependant or conservatively managed chronic kidney
disease patients. However, post-transplanted patients’ perform-
ance was signiﬁcantly low compared with that of healthy con-
trols (and standardized normative data) in the domains of exec-
utive functioning (g¼0.283), verbal ﬂuency (g¼0.657) and
language (g¼0.573).
Conclusions. Two key issues arise from this review. First,
domain-speciﬁc cognitive improvement occurs in patients after
successful transplantation. Nevertheless, transplanted patients
still performed signiﬁcantly below healthy controls in some
domains. Second, there are important shortcomings in existing
studies; the length of follow-up is typically short and only lim-
ited neuropsychological test batteries are employed. These fac-
tors are important in order to support the recovery of cognitive
function among patients following renal transplant.
Keywords: chronic kidney disease, cognition, dialysis, kidney
transplant, systematic review
INTRODUCTION
Chronic kidney disease (CKD) can result from multiple factors,
including hypertension, diabetes and genetic disorders [1–3].
End-stage kidney disease (ESKD) is the fifth and most severe
category of CKD and is defined as the inability of the kidneys to
metabolize and remove waste substances such as creatinine [4].
Patients suffering from ESKD depend on renal replacement
therapy (RRT) for survival. RRT options include kidney trans-
plantation, peritoneal dialysis (PD) and haemodialysis (HD) [5]
and transplantation is currently the recommended gold stand-
ard [6]. The majority of transplanted patients spend a period of
months or years dependent on dialysis before being trans-
planted, although a minority (22%) receive a transplant pre-
emptively, bypassing the need for maintenance dialysis [7].
CKD is a debilitating illness with a broad impact on physical
health and psychological function (both well-being and cognitive
function) [8, 9]. CKD has been shown to be an independent risk
factor for cognitive decline across multiple domains of function-
ing, including memory and spatial reasoning [10]. The onset and
course of cognitive difficulties is poorly understood, but there is
evidence that cognitive function may improve following kidney
transplantation [11]. There are various potential mechanisms to
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account for the cognitive change experienced by CKD patients.
For instance, the impact of CKD on cerebral vasculature may
affect cognition [12]. Previous research has shown that reduced
creatinine clearance (between 15 and 60mL/min) is associated
with a 43% increase in stroke and white matter deterioration,
which are factors associated with dementia and cognitive impair-
ments [13]. In addition, CKD patients often have elevated homo-
cysteine levels [14], which in turn have been associated with
subclinical cerebral infarcts [15], high carotid intima-media
thickness [16] and cerebral white matter changes [17], as
revealed by magnetic resonance imaging studies employing dif-
fusion -weighted sequences. While these are subclinical associa-
tions, they can prompt cognitive impairment through multiple
mechanisms such as cerebral systemic inflammation, oedema
and atherosclerosis [18]. Although there are only limited data,
another putative mechanism for cognitive decline in this group
relates to a possible increased risk of vascular dementia in
patients with CKD [19]. Vascular mechanismsmay also underlie
cognitive changes noted in patients receiving dialysis [20]. This
may be caused by hypotension (a common result of rapid reduc-
tion of blood volume during HD), cerebral oedema due to excess
water in the brain because of water retention or even cortical
atrophy as a result of dialysis [21]. Anaemia could also contrib-
ute to cognitive difficulties experienced by those with CKD. The
prevalence of anaemia has been found to be twice as high among
CKD patients (15.4%) compared with the general population
(7.6%) [22]. Furthermore, the prevalence of anaemia has been
shown to increase with the severity of CKD, from 8.4% at Stage 1
to 53.4% at Stage 5 [22]. Unlike other mechanisms, which reflect
permanent alterations of neural function, reversal of anaemia is
associated with a concomitant improvement in cognitive func-
tion [23]. Thus there are several potential mechanisms that con-
tribute to poor cognitive status in CKD patients, and the
question remains open as to whether these impairments recover
with effective treatment of CKD.
Some studies suggest that cognitive decline of CKD can to
some extent be reversed following kidney transplantation [11,
24–26], while others indicate that cognitive decline may be exa-
cerbated by the adverse effects of immunosuppressive medica-
tions that patients are required to take after transplantation [27–
30] or due to mood disturbances. Cognitive impairments may
impact on post-transplant daily living. For instance, decreased
cognitive functioning (e.g. in memory and executive function
[31]) may lead to lapses in the self-administration of and adher-
ence to complex immunosuppressive medication regimes [32].
There is mixed evidence regarding the nature of cognitive
changes following kidney transplantation. Identification of the pre-
cise nature of cognitive change is imperative for pre-transplant
advice and post-transplant clinical support. The aim of this meta-
analysis was to examine which cognitive domains are impacted fol-
lowing kidney transplantation and how performance compares
with non-transplanted patients or healthy controls/normative data.
MATERIALS AND METHODS
The review complies with the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines
[33] (Supplementary data, Table S1).
Review strategy
Three databases were searched through the Ovid platform:
Embase (1947–February 2016), MEDLINE (1946–February
2016) and PsychINFO (1806–February 2016). No limits were
applied for publication dates. Search terms were categorized
into three blocks: Block 1, renal or kidney; Block 2, immuno-
suppression or transplant and Block 3, cognitive function* or
cogniti* or neuropsycho* or neuroimag* or memory or lan-
guage or attention or executive or spatial. A search was then
performed using the AND function combining the results of the
three blocks. Duplicates were omitted. Reference lists were hand
searched (backwards search) and a forward (citation) search
was conducted to identify additional relevant publications.
Where relevant, authors were contacted to request further
information about the methodology or data.
Studies were conducted if they (i) reported cognitive
performance data for kidney transplant patients; (ii) included
relevant comparison data of either pre- or post-transplant
data, dialysis patients, CKD patients, healthy controls or
standardized norms; (iii) were written in English and (iv) age
>18 years. Exclusion criteria included reviews of conference
abstracts, case studies, dissertations or book chapters. The fol-
lowing information was systematically extracted from each
identified article and entered into a pre-designed data acquisi-
tion sheet: authors (year of publication), aims, design, country
of origin, sample size (age range), comparison groups, treat-
ment type, stage of CKD, prospective follow-up period, length
of immunosuppressive treatment, time tested after transplant
surgery, cognitive domains tested and findings.
Methodological quality assessment
Selected articles underwent quality assessment using an
11-item quality assessment tool [34]. Two researchers under-
took this process independently and issues were resolved
through consensus. Scoring was dependant on the extent to
which a study fulfilled each criterion: a score of two was
assigned if a study fully met the criterion, one was assigned if it
partially met the criterion and zero was assigned if a criterion
was not met. Criteria were excluded if they were not applicable
to a particular study. An average score was calculated and stud-
ies were categorized as high quality (score > 1.50), medium
(score 1.00–1.50) or low quality (score< 1.00).
Meta-analysis procedure
Outcome measures were grouped into nine cognitive
domains (Supplementary data, Table S2): attention, executive
function, general cognitive status, information andmotor speed,
spatial reasoning, language, verbal fluency, verbal memory and
visual memory. Three separate meta-analyses were
performed: (i) within subjects pre- versus post-transplant,
(ii) transplanted versus non-transplanted patients and (iii)
transplanted versus healthy matched controls and standardized
normative data. Data from each study could be included in one,
two or all three analyses depending on study design. Random
effects models were used to calculate the effect sizes (Hedges’ g)
for changes in cognitive performance in each of the nine
domains. The Hedges’ g effect size is a measure of the difference
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between groups reported on a common dimensionless scale. It
is obtained by dividing the difference of each measure by the
pooled and weighted standard deviation of the sample. An effect
size (g) of 0.2 is regarded as being small, because 85% of the area
from normally distributed values shared between two groups of
equal size and variability overlap; 0.5 is regarded as medium,
because 66% of normally distributed values overlap; and 0.8 is
regarded as large, because only 20% of combined normally dis-
tributed values overlap [35].
Heterogeneity between articles was assessed using I2, s2 and
Q tests. The I2 statistic is especially relevant to this review, since
it allows researchers to approximate the proportion of total var-
iation in the effect sizes across studies. Higher I2 values indicate
higher levels of heterogeneity. These proportions have been
categorized into low, moderate and high (25%, 50% and 75%,
respectively) I2 values representing various levels of heterogene-
ity [36]. Publication bias was assessed using funnel plots with
the trim and fill method (Figure 2). Meta-analysis calculations
were undertaken with Comprehensive Meta-Analysis software
(version 2; Biostat, Englewood, NJ, USA) [37].
RESULTS
The search methodology identified 472 articles, which was
reduced to 458 by eliminating duplicates (Figure 1). After
screening titles and abstracts, 442 non-relevant articles were
excluded. The remaining 16 articles were retrieved in full text
for review against the inclusion and exclusion criteria. Three
articles were excluded as they were not relevant to the review
[38–40] and a further two studies were excluded because they
reported no post-transplant comparative date [41, 42]. A back-
wards search identified one article and a forwards search
revealed two further articles. Of these 14 articles, 3 were
excluded because they were systematic reviews or a dissertation
without empirical findings. In addition, one article had a 40%
participant overlap with a previous study by the same authors
and therefore the earlier article was excluded [45, 46]. Ten
articles remained; six studies were categorized as high quality
[11, 24, 26, 30, 46, 47] and four as moderate quality [14, 25, 48,
49]. Four studies used a longitudinal design in which follow-up
assessment periods ranged from 6 to 28months post-
transplant.
The most frequently assessed domain across all studies was
verbal memory (Supplementary data, Table S3), which was
assessed across seven studies. Performance scores from one
assessment in an included study were omitted because distinct
scores were not provided for the forward and backward parts of
the digit span test [47]. Study sample sizes ranged from 15 to
262 (Table 1), with a total sample size of 1118. The age range
across the studies was 42–59 years. Publication bias was assessed
FIGURE 1: Overview of search methodology: (i) Koushik et al. [38], Olbrisch et al. [39] and Wolkowitz et al. [40]; (ii) Hailpern et al. [41] and
Kurella et al. [42]; (iii) Carrasco et al. [43] and Gutierrez-Dalmau and Campistol [44] and (v) Harciarek et al. [45].
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by visually inspecting funnel plots for asymmetry (Figure 2).
Some bias was present, but when plots were re-analysed with
the trim and fill method, no significant changes in effect size
were found.
Cognitive findings by domain
All nine cognitive domains (Supplementary data, Table S2)
were entered into the analyses.
Within subjects pre- versus post-transplant
Three studies in this analysis included pre-transplant
patients on HD [14, 24, 46] and one study included pre-trans-
plant patients on HD or PD [26].
Post-transplantation performance showed significant
improvement in general cognitive status {g¼ 0.526 [95% confi-
dence interval (CI) 0.138–0.915], P¼ 0.008, I2 ¼ 0.000}, infor-
mation and motor speed [g¼ 0.558 (95% CI 0.059–1.057),
FIGURE 2: Funnel plots assessing publication bias by analyses conducted, cognitive domain effect sizes and signiﬁcance level. Hollow symbols
represent publication bias of studies included and solid symbols represent imputed studies required to avoid publication bias.
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Table 1. Summary of study key signiﬁcant ﬁndings and sample size information
Study/date Sample and age (years) Design Comparative group,
n (age 6 SD)
Time tested post-
transplant
Outcomes: domains
assessed
Kramer et al. [14],
Austria
15 transplant patients
(456 13) previously
on HD
Prospective longitudinal
Within-subjects pre-
transplant dialysis
patients assessed after
transplantation compared
with healthy controls; 14
6 5-month follow-up
Same sample assessed
after transplant HD:
15 (456 13)
Healthy controls:
45 (456 13)
14months General cognitive status
Information and motor
speed
Harciarek et al. [46],
Poland
27 transplant patients
(46.16 10.9) previously
on HD: 17, PD: 10
Prospective longitudinal
Within-subjects pre-
transplant dialysis
patients assessed after
transplantation compared
with dialysis and healthy
controls; 8-month and
20-month follow-up
Subsample of transplant
patients assessed after
transplantation com-
pared with those still
on dialysis:
Still dialysing:
18 (44.9611.8)
HD: 12
PD: 6
Healthy controls:
30 (47.236 10.2)
None stated Attention
Executive function
General cognitive status
Information and motor
speed
Language
Spatial reasoning
Verbal ﬂuency
Verbal memory
Visual memory
Griva et al. [26],
United Kingdom
28 transplant patients
(follow-up age not stated)
previously on HD: 10,
PD: 18
Prospective longitudinal
Within-subjects pre-
transplant dialysis
patients assessed after
transplantation; 6-month
follow up
Same sample assessed
after transplant dialysis:
28 (44.046 12.01)
HD: 10
PD: 18
Standardized norms
6months Executive function
Information and
motor speed
Verbal memory Visual
memory
Radic et al. [24],
Croatia
21 transplant patients
(45.146 7.86)
previously on HD
Prospective longitudinal
Within-subjects pre-
transplant dialysis
patients assessed after
transplantation; 206 8-
month follow-up
Same sample assessed
after transplant
HD: 21 (45.146 7.86)
20.5months Executive function
Spatial reasoning
Verbal memory
Griva et al. [25],
United Kingdom
117 transplant patients
(50.266 12.33)
Cross-sectional transplant
patients compared with
dialysis patients
Dialysis:
145 (50.126 14.26)
HD: 77
PD: 68
None stated Executive function
Information and motor
speed
Verbal memory
Troen et al. [11], Israel 183 transplant patients
(546 9.5)
Cross-sectional transplant
patients assessed only
compared with norms
Standardized norms None stated Executive function
Information and motor
speed
Spatial reasoning
Verbal memory
Gelb et al. [48],
Canada
42 transplant patients
(55.246 10.96)
Cross-sectional transplant
patients compared with
healthy controls and CKD
patients
CKD patients:
45 (59.676 11.88)
Healthy controls:
49 (57.006 13.59)
None stated Executive function
Verbal memory
Martinez-Sanchis et al.
[30], Spain
32 transplant patients
(42.696 8.28)
Cross-sectional transplant
patients compared with
healthy controls
Healthy controls:
10 (37.206 9.90)
None stated Attention
Executive function
Information and motor
speed
Verbal ﬂuency
Verbal memory
Visual memory
Anwar et al. [47],
Egypt
50 transplant patients Cross-sectional transplant
patients compared with
dialysis and healthy
controls
Dialysis: 50 (456 9.5)
Healthy controls: 30
(456 9.5)
None stated Executive function
General cognitive status
Information and motor
speed
Ozcan et al. [49],
Turkey
69 transplant patients
(50.96 16.5)
Cross-sectional transplant
patients compared with
dialysis patients
Dialysis: 112 (51.216
13.45)
HD: 54 (51.16 12.5)
PD: 58 (51.336 14.4)
None stated General cognitive
status
Age6 SD refers to mean age6 standard deviation.
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P¼ 0.029, I2 ¼ 49.693], spatial reasoning [g¼ 0.376 (95% CI
0.033–0.719), P¼ 0.053, I2 ¼ 0.000], verbal memory [g¼ 0.759
(95% CI 0.411–1.202), P¼ 0.002, I2 ¼ 22.201] and visual
memory [g¼ 0.690 (95% CI 0.291–1.089), P< 0.001, I2¼ 0.000]
(Figure 3). No significant effect sizes were observed for the other
domains.
Transplanted versus non-transplanted patients
Kidney transplant patients’ scores were compared with non-
transplanted dialysis-dependant patients in four studies, one of
which measured cognition in patients who were on HD [47],
while the remaining three assessed patients who were dialysing
through HD or PD [25, 46, 49]. One study was also included in
this analysis that compared kidney transplant patients with
individuals with CKD [estimated glomerular filtration rate
(eGFR)<60mL/min/1.73 m2] who had not received a trans-
plant or dialysis [48]. Scores of patients measured after they had
been transplanted and compared with patients who are dialysis-
dependant or CKD managed showed significantly better
general cognitive status performance [g¼ 0.425 (95% CI 0.203–
0.648), P< 0.001, I2 ¼ 0.000], information and motor speed
[g¼ 0.457 (95% CI 0.054–0.860), P¼ 0.026, I2¼ 71.942], spatial
reasoning [g¼ 0.596 (95% CI 0.011–1.203), P¼ 0.054, I2
¼ 0.000], verbal memory [g¼ 0.477 (95% CI 0.010–0.944),
P¼ 0.046, I2 ¼ 76.927] and visual memory [g¼ 0.792 (95% CI
0.185–1.399), P¼ 0.011, I2 ¼ 0.000]. However, no significant
FIGURE 3: Cognitive performance by domains of transplant patients’ baseline performance compared with follow-up. Transplant patients
compared with non-transplanted patients and transplant patients compared with matched healthy controls and standardized norms.
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differences were found in domains of attention, executive func-
tioning, language and verbal fluency (Figure 3).
Transplanted versus healthy matched controls and
standardized norms
Transplanted patients’ scores were compared with healthy
matched control participants or standardized norms. One study
compared patients with healthy controls first while they were
dependent on HD and then after they had been transplanted
[46]. Another study made similar comparisons but did not re-
test healthy controls after HD patients were transplanted [14].
Five further studies were cross-sectional and assessed cognition
at one time point following transplantation and compared with
healthy controls or standardized norms [11, 30, 47, 48]. Healthy
controls were matched to transplanted patients according to
age, mean years of education, gender, baseline intelligence
(Mini Mental State Examination, vocabulary), physical activity,
occupation, marital status, comorbid conditions and biological
factors (haemoglobin, serum creatinine, blood urea nitrogen,
eGFR) across studies.
Significant differences were found in executive functioning
[g¼0.283 (95% CI0.535 to0.030), P¼ 0.030, I2¼ 0.000],
language [g¼0.573 (95% CI 1.095 to 0.051), P¼ 0.032,
I2¼ 0.000] and verbal fluency [g¼0.657 (95% CI 1.080 to
0.233), P< 0.01, I2 ¼ 0.000], in which post-operative trans-
plant patients scored below healthy matched controls and
standardized norms (Figure 3). No significant differences were
found in domains of attention, spatial reasoning, information
and motor speed, general cognitive status, verbal memory and
visual memory across studies (Figure 3).
DISCUSSION
The aim of this meta-analysis was to examine which cognitive
domains were impacted following kidney transplantation and
how performance compares with non-transplanted patients or
healthy controls/normative data. The meta-analysis identified
that cognitive performance is better in patients who have
received a transplant compared with those who are dialysis
dependant or CKD managed in the domains of verbal and vis-
ual memory, spatial reasoning, processing speed and general
cognitive status. While reviewing changes within people who
received a transplant, significant improvements were apparent
in the domains of general cognitive status, information and
motor speed, spatial reasoning, verbal memory and visual mem-
ory. These changes appear to be stable, as cognitive improve-
ment remained measurable at the 1-year [46] and even the 2-
year follow-up [24]. However, these findings highlight that
transplant patients are unlikely to recover fully after transplant
surgery, as patients still performed significantly below healthy
matched controls/normative data in three cognitive domains
(executive function, verbal fluency and language). Moreover,
cognition in some domains (attention, executive function, ver-
bal fluency and language) did not improve after transplantation
(even with long-term follow-up) compared with pre-transplant
levels and was not superior compared with dialysis patients.
Improved understanding of the aetiology of cognitive
impairment after kidney transplantation may enable
development of interventions to improve or maintain cognition
[50, 51]. Determining whether there are effects upon cognition
of specific immunosuppressive medication has important clini-
cal implications. Impairments in attention and executive func-
tioning in kidney transplant patients treated with either
tacrolimus or sirolimus have been reported [30]. In contrast, no
such cognitive side effects were reported among cyclosporine-
treated patients, who performed similarly to healthy controls
after transplantation [30]. Unfortunately, any discrete cognitive
outcomes related to medication treatments in the study had to
be averaged across immunosuppressive groups to be included
in the review, losing the effects of individual immunosuppres-
sive therapies on cognition. However, it is well established that
immunosuppressive medication can impact neural function. In
normal central nervous system function, the cytokine interleu-
kin-2 (IL-2) has been demonstrated to be essential for neuro-
genesis and cognition [52]; its production and action is
inhibited by a number of immunosuppressive drugs, including
tacrolimus, cyclosporine and sirolimus [53–55]. In addition,
dopamine and acetylcholine have been found to be innervated
to the prefrontal and parietal regions [56], which may be
involved in executive function tasks requiring working memory,
visuospatial working memory, planning and inhibition [29].
Innervation of these neurotransmitters has been shown to be
mediated through IL-2 [57]. Thus interference from immuno-
suppression in the midbrain area (substantia nigra), where IL-2
is abundant, could lead to a blockade in neurotransmitter proc-
esses essential for executive functions [58]. The severity of
immunosuppressive-induced cognitive changes appears to be
reversible and related to the length of immunosuppressive
exposure rather than to drug dosages [59–61]. Since tacrolimus
and sirolimus have been associated with cognitive impairment
in past research [30], it is important to assess the individual
effects of specific immunosuppressant medications on cogni-
tion. Moreover, this is due to the neural pathways in which
these drugs inhibit IL-2. Tacrolimus inhibits IL-2 through
calcineurin inhibition [62], whereas sirolimus inhibits T-cell
and B-cell activation through action on mammalian target of
rapamycin, which regulates cell growth, proliferation and motil-
ity [63]. These underlying mechanisms could have pleiotropic
effects influencing various phenotypic traits [64, 65]. The possi-
bility of medication-specific cognitive impairment should be
one of the issues discussed to fully prepare and inform potential
transplant recipients.
There are several alternative mechanisms that might
underlie sustained cognitive impairment in kidney transplant
patients. There is a well-established link between mood dis-
turbance and cognitive changes, particularly in the domains
of attention, executive function and working memory [66–
68]. Prevalence rates of depression in kidney transplant
patients range between 13 and 46% [69–71]. While some
studies of depression in dialysed patients who subsequently
received a transplant typically report lower levels of depres-
sion after transplantation [26], others found no significant
differences or interactions in depression levels between dia-
lysed patients pre- and post-transplantation [45, 46]. The lit-
erature illustrates that depression is prevalent in transplant
patients. However, uncertainty exists about the carry-over
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effects of depression from dialysis to transplantation due to
mixed findings.
Posterior reversible encephalopathy syndrome (PRES) is
an identified mechanism of cognitive impairment and may
affect brain function in kidney transplant patients in the short
term [72]. In most cases, irregularities are confined to bilat-
eral frontal lobes, right occipital cortices, and parietal regions
[73], which are regions important to executive functions [74,
75]. However, longitudinal follow-up studies included in this
review suggest that symptoms of PRES are resolved in the
long term compared with pre-transplant levels [14, 24, 46].
Investigations of PRES have been explored, but only on a case
study [76] or small sample size basis [77]. Therefore, the role
and identification of PRES warrants further investigation in
longitudinal designs. Other variables including cerebrovascu-
lar disease, subclinical infarcts and carotid intima-media
thickness could merge with more acute risk factors to influ-
ence cognitive changes after transplantation [16, 17].
Delineating between these chronic and acute risk factors
should be explored through further research for effective
management. Also possible is that improved toxin clearance
following transplantation results in improved cognitive per-
formance [46]. Poorer toxin clearance (indicated by a lower
eGFR) has been shown to correlate with poorer performance
on tests of memory and executive function [11]. Studies that
assess the trajectory of cognitive function and how that corre-
lates with toxin clearance would help test this hypothesis.
There are several limitations in the meta-analysis presented
here. Only four studies assessed cognition longitudinally
(6months to 2 years follow-up periods). Moreover, it should be
noted that only English-language studies were included and
that non-English-language studies may influence the overall
findings reported here. Additionally, discrepancies exist
between global approaches to the management of renal trans-
plant patients and practices change over time. Therefore, the
meta-analysis and review conducted should be interpreted with
caution, as location and time are relevant to outcomes. Another
concern is that studies lack large enough sample sizes required
to match for multiple comparisons across dialysis, transplant
and healthy patients. Therefore, study designs lacked the power
to compare for multiple confounds across samples and findings
may be biased. Publication bias was apparent in the within-
subjects comparisons and non-transplant versus transplant
patient comparisons. However, when the trim and fill method
was used to adjust for the suspected bias, only marginal effect
size shifts were apparent, indicating no significant changes even
with imputed studies. In addition, studies employed study-
specific neuropsychological measures to assess cognition, which
makes it challenging to compare and group tests into domains
because sensitivities and specificities of tests may differ accord-
ing to the population being studied [78]. Furthermore, cut-off
scores defined as being abnormal or normal may vary for each
incorporated test [78].
Organization of assessments was grouped into cognitive
domains with specific distinctions made between certain cogni-
tive domains. Categorization of tests primarily dependent on
language and executive control abilities were classified as verbal
fluency. However, those tasks involving predominantly execu-
tive functions such as inhibition and categorization [79] with a
working memory retrieval component were grouped in the
executive function domain. Arguably, the validity of both verbal
fluency and executive function assessments have been found to
overlap [80]. Due to the hybrid nature of both the domains, the
number of possible variations that tests could be classified as
could vary overall outcomes. The development of a cognitive
taxonomy for the classification of assessments is required and
recommended to limit this shortcoming.
The analysis included a pre- versus post- within-subjects
design. One weakness of the studies in this analysis (pre- versus
post-) is that a control group was not used to control for
changes in cognition of patients over time [81]. Therefore, a
control group of ESRD patients actively waiting for a transplant
from the deceased donor list is recommended in further
research. This group represents the closest match to transplant
patients postoperatively and may assist in controlling for con-
founding factors among both groups over time.
We know of no interventions that have been developed spe-
cifically to mitigate the effects of cognitive changes among
transplant patients. However, cognitive interventions have been
shown to be effective in improving cognitive functioning in
other groups, including executive functioning after brain injury
and mild cognitive impairment in other clinical populations,
and it would be useful to test their benefit for kidney transplant
recipients [82, 83]. Our findings provide evidence for restora-
tion of cognitive function in transplanted patients to pre-end-
stage but not normal levels in the majority of cognitive domains.
There is a need for research that identifies the basis for this
improvement. The recovery of cognitive abilities may not
extend to the important domain of executive functions and may
be inhibited by some groups of immunosuppressive medication.
Thus, there is a strong case for additional research aimed at sup-
porting optimal cognitive outcomes among patients receiving
kidney transplants.
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